Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice—an updated analysis
*Department of Medical Oncology, London Regional Cancer Program, London, ON.;†Schulich School of Medicine, Western University, London, ON.;‡Department of Social Sciences, Western University, London, ON.